Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

720 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Not Yet Recruiting

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

NCT06661148

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +16 more
Locations
  • Epigenic Therapeutics Investigational Site Westmead, New South Wales, Australia
  • Epigenic Therapeutics Investigational Site Hong Kong, China
  • Epigenic Therapeutics Investigational Site Grafton, Auckland, New Zealand
  • Epigenic Therapeutics Investigational Site Christchurch, New Zealand
View Trial Details
Completed

Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection

NCT04749368

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Investigative Site 61002 Kingswood, New South Wales, Australia
  • Investigative Site 61001 Westmead, New South Wales, Australia
  • Investigative Site 61004 Herston, Queensland, Australia
  • Investigative Site 88602 Changhua, Taiwan, China
View all 28 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

NCT05630820

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Centreville, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 171 locations
View Trial Details
Completed

Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)

NCT05630807

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Davis, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Palo Alto, California, United States
View all 177 locations
View Trial Details

Related conditions